Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
As of September 2024, Proprio’s Paradigm platform has been used in over 50 successful spine surgeries. Clinical use has demonstrated a tenfold reduction in radiation-based imaging compared to traditional methods. The company reports improved accuracy and efficiency for both experienced surgeons and residents. The system synthesizes real-time multi-modal data to create a digital twin of patient anatomy for intraoperative guidance. Platform expansion to leading hospitals in the US and internationally ongoing through 2025. Thousands of terabytes of data collected; extensive simulation/testing performed during development. No direct therapeutic clinical trial results as it’s not a drug/device with therapeutic effect but an enabling technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proprio.